Radiobiological Evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines: Radiobiological basis for a Phase II Clinical Study Protocol (CLEOPATRA)

被引：0

|

作者：

Combs, S. E. ^{[1
]}

Kieser, M. ^{[1
]}

Wick, W. ^{[1
]}

Unterberg, A. ^{[1
]}

Bohl, J. ^{[1
]}

Elsaesser, T. ^{[1
]}

Weber, K. -J. ^{[1
]}

Schulz-Ertner, D. ^{[1
]}

Kraft-Weyrather, W. ^{[1
]}

Debus, J. ^{[1
]}

机构：

[1] Univ Klinikum Heidelberg, Heidelberg, Germany

来源：

ONKOLOGIE | 2010年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：59 / 59

页数：1

相关论文

共 3 条

[1] Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines
Combs, Stephanie E.
Bohl, Jessica
Elsaesser, Thilo
Weber, Klaus-Josef
Schulz-Ertner, Daniela
Debus, Juergen
Weyrather, Wilma K.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2009, 85 (02) : 126 - 137
[2] Radiobiological evaluation and correlation with the Local effect Model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines
Kraft-Weyrather, W.
Bohl, J.
Elsaesser, T.
Schulz-Ertner, D.
Debus, J.
Combs, S. E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S705 - S705
[3] Clinical results of the randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma (CLEOPATRA trial; NCT01165671)
Combs, S.
Rieken, S.
Kessel, K. A.
Welzel, T.
Adeberg, S.
Koenig, L.
Haselmann, R.
Jaekel, O.
Preussler, S.
Kieser, M.
Wick, A.
Unterberg, A.
Debus, J.
Bernhardt, D.
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S38 - S39